Dr Chapman completed her PhD at the University of Sydney and Woolcock Institute of Medical Research and is now a postdoctoral research fellow funded by the CogSleep Centre of Research Excellence to Optimise Sleep in Brain Ageing and Neurodegeneration. She is also a key member of the Sleep Clinical Trials team.
Her research focusses on the daytime consequences of poor sleep, and the measurement of biological markers to identify the effects of poor sleep on brain health. Her current projects are looking into blood-based biomarkers for dementia in patients with obstructive sleep apnea, and she was recently awarded the Rob Pierce Grant from the Australasian Sleep Association to continue this work. Dr Chapman’s work also includes examining brain activity during sleep (quantitative EEG analysis) in multiple patient groups including those with sleep disorders and mild cognitive impairment.
Dr Chapman is a member of the Neuroscience Council of the Australasian Sleep Association and CogSleep Academy, and recently convened the CogSleep Symposium in 2022.